ASCO Annual Meeting: Ovarian Cancer | Conference

Kathleen Moore, MD, on the Key Takeaways of 3 Clinical Trials Examining Niraparib in BRCA-Mutant Ovarian Cancer
June 27, 2021

Kathleen Moore, MD, discusses findings compiled from 3 clinical trials of niraparib in patients with ovarian cancer.

R Tyler Hillman, MD, PhD, on Important Contributors Needed to Treat Ovarian Granulosa Cell Tumors
June 18, 2021

An expert emphasizes how a big team is needed to properly employ the different therapeutic modalities needed to treat patients with ovarian granulosa cell tumors.

No Difference in Survival Noted With Longer Duration of Bevacizumab for Ovarian Cancer
June 07, 2021

Doubling treatment duration of bevacizumab did not lead to better survival in patients with ovarian cancer who were treated on a phase 3 trial.